Friday, 28 April 2017 20:41

Anticoagulation news items. Week commencing 24th April 2017

Meta-Analysis of the Relative Efficacy and Safety of Oral P2Y12 Inhibitors in Patients With Acute Coronary Syndrome

American Journal of Cardiology

Meta-analysis of 9 RCTs (n= 106,288) suggests that overall, ticagrelor may have the best net efficacy and safety profile among currently approved oral P2Y12 inhibitors for the treatment of acute coronary syndrome.



The above records have been identified by UKMi and feature in the NICE Medicines Awareness Service. Further details on this service can be found at: